Identifying issues early on in clinical trials can help study teams make rapid and effective decisions for achieving better results. For the past two decades, the use of clinical oversight solutions has been gaining popularity among industry leaders. However, taking full advantage of data-driven clinical oversight solutions to drive unique clinical trials forward remains a challenge for many small-to-medium life science companies.
Sharing their expertise, Axiom's Founder & CEO Andrew Schachter and Senior Director of Global Clinical Management, Brian Dempster, will present "Owning Your Data: The Evolution of Clinical Oversight." They will provide an overview of the evolution of clinical oversight and how to use a unified platform to increase data oversight and efficiency for all clinical trial roles.
Join our webinar to be a part of this exciting discussion! Meet our expert speakers and pose your questions during our live broadcast. Register today and view our presentation "Owning Your Data: The Evolution of Clinical Oversight" on Friday, October 22, 2021, at 1 pm EDT.
Presented by
Andrew Schachter,
Axiom Founder and CEO
As Founder and Chief Executive Officer of Axiom Real-Time Metrics, Andrew Schachter delivers the visionary leadership integral to the company's 20 years of eClinical technology and Managed services success.
Under his leadership, Axiom has grown into a well-established and recognized innovator and leader in the small-to-medium life science Clinical solutions landscape. His expertise and profound understanding of complex clinical studies have transformed the Axiom global team into a devoted and virtuous leader in the industry.
Over the past 20 years, Schachter's passion for innovating technology solutions continues to drive Axiom to empower smarter and faster clinical studies and yield better study results for helping patients worldwide.
Today, Axiom's state-of-the-art unified eClinical Suite Fusion has over 15 powerful and highly configurable modules. In addition, Axiom also offers global clients intelligent Data Management, Data Analytics, Pharmacovigilance & BioStats services.
Brian Dempster,
Global Clinical Management Senior Director
Brian Dempster has over 25 years of clinical development experience, gained across a variety of therapeutic areas and geographical regions. He began his career as a CRA before being accepted to Amgen’s Leadership and Management Program. During a decade at Amgen, Brian held program leadership positions in Oncology, Endocrinology and Bone Health in Europe, Canada, and the US. In 2014 Brian joined Vital Therapies (VTL) where he was instrumental in the creation and execution of clinical development strategy, overseeing the entire Phase II and Phase III programs of VTLs combined device/biotherapeutic system for the treatment of liver failure. Utilizing the Fusion® e-clinical suite in partnership with Axiom. Before Joining Axiom, Brian led the clinical development group at Endologix, where he oversaw the global team involved in the pre-approval and post-market clinical development of Endologix’s products, serving patients with need for abdominal aortic aneurysm sealing and repair. Brian has a thorough understanding of the clinical development process and has used this to successfully bring products to market. Including leading teams through regulatory inspections, in relation to submissions, to FDA, MHRA and PMDA.
